Anne Marbarger

Anne Marbarger is the CEO of Curebound, a San Diego-based organization committed to accelerating cures for cancer by funding collaborative research among San Diego’s top cancer research centers.Curebound is well on its way to a bold goal of raising and investing $100 million in game-changing research projects that show promise of translating basic discoveries to clinical and commercial stages.

Anne steps into the Curebound CEO position after having led Curebound’s predecessor organization, Padres Pedal the Cause for six years during which time the organization raised $10 million for cancer research. Under Anne’s leadership, Curebound expands beneficiary research partnerships with Moores Cancer Center at UC San Diego Health, the Salk Institute, Sanford Burnham Prebys, and Rady Children’s Hospital to now include two new powerhouses: Scripps Research and La Jolla Institute for Immunology.

A natural consensus-builder and community collaborator, Anne leads the transformation from Padres Pedal the Cause to Curebound including the creation of a new Scientific Advisory Board to guide the organization’s investments, an acquisition of partner organization, the Immunotherapy Foundation, and formation and rollout of the Curebound brand. Curebound will build off this collective foundation of $26 million awarded, and 95 innovative research grants and clinical trials funded, and one of the largest cancer fundraising events on the West Coast.

Prior to joining Pedal the Cause in 2015, Anne worked in management consulting in Washington, DC, within Deloitte Consulting’s federal human capital practice. Earlier in her career, she served as an intelligence analyst at the United States Treasury Department with a focus on major Middle East terrorist organization illicit funding sources and use of the US financial system. She holds a Bachelor’s Degree in Government from Dartmouth College and an MBA from George Washington University.